A
Andreas A. Argyriou
Researcher at University of Patras
Publications - 180
Citations - 6489
Andreas A. Argyriou is an academic researcher from University of Patras. The author has contributed to research in topics: Peripheral neuropathy & Medicine. The author has an hindex of 38, co-authored 162 publications receiving 5527 citations. Previous affiliations of Andreas A. Argyriou include University of Verona & General University Hospital of Patras.
Papers
More filters
Journal ArticleDOI
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
TL;DR: The features of chemotherapy-induced peripheral neurotoxicity (CIPN) resulting from the administration of these drugs are reviewed with a focus on new classes of promising antineoplastic agents, such as epothilones and proteasome inhibitors.
Journal ArticleDOI
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
TL;DR: It is increasingly recognized that BIPN may be a proteasome inhibitor class effect, producing primarily a small fiber and painful, axonal, sensory distal neuropathy.
Journal ArticleDOI
A review on oxaliplatin-induced peripheral nerve damage.
Andreas A. Argyriou,Panagiotis Polychronopoulos,Gregoris Iconomou,Elisabeth Chroni,Haralabos P. Kalofonos +4 more
TL;DR: The pathogenesis, incidence, risk factors, diagnosis, characteristics and management of OXLIPN are reviewed and the areas of future research are highlighted.
Journal ArticleDOI
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Guido Cavaletti,David R. Cornblath,Ingemar S. J. Merkies,Tjeerd J. Postma,Emanuela Rossi,Barbara Frigeni,Paola Alberti,Jordi Bruna,Roser Velasco,Andreas A. Argyriou,Haralabos P. Kalofonos,Dimitri Psimaras,Damien Ricard,Andrea Pace,Edvina Galiè,Chiara Briani,C. Dalla Torre,Catharina G. Faber,Roy I. Lalisang,W. Boogerd,W. Boogerd,Dieta Brandsma,Susanne Koeppen,Jörg Hense,Dawn J Storey,S. Kerrigan,Angelo Schenone,Sabrina Fabbri,Maria Grazia Valsecchi,Anna Mazzeo,Antonio Toscano,Brigitte A. Brouwer,B. Piras,C. Dominguez gonzalez,Chiara Tomasello,D. Binda,D. Cortinovis,E. Lindeck pozza,Els K. Vanhoutte,Francesca Lanzani,Francesca Pastorelli,Giuseppe Altavilla,Giuseppe Granata,I. Ghignotti,J. Heimans,Laura Mattavelli,Luca Padua,L. Reni,Mayienne Bakkers,Marta Campagnolo,M.E. Cazzaniga,M. Eurelings,Massimo Leandri,Marta Lucchetta,M. Penas prado,M. Russo,M Piatti,P. Bidoli,Robin Grant,R. Plasmati,R. J. Meijer,Susan G. Dorsey,Stefania Galimberti,Wolfgang Grisold,A. Pessino +64 more
TL;DR: Good validity and reliability scores were demonstrated for the set of selected impairment and quality-of-life outcome measures in CIPN and future studies are planned to investigate the responsiveness aspects of these measures.
Journal ArticleDOI
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
TL;DR: The spectrum of chemotherapy-induced peripheral neuropathy characteristics is discussed so as to highlight areas of future research to pursue on the topic and allow the registration and analysis of reliable data on the true characteristics of CIPN, eventually leading to potential preventive and therapeutic interventions.